First-trimester asthma controller medication use and major congenital malformation risk in offspring of women with asthma: A nationwide population-based cohort study
Journal of Allergy and Clinical Immunology · 2026-07 · 158 (1) · 52-61
DOI: 10.1016/j.jaci.2026.03.013 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-07. Verfasst von Xue-Feng Jiao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Center, CHU Sainte-Justine, Montreal, Quebec, Canada; Department of Pharmacy/Evidence-Based Pharmacy Center, West China Second University Ho…. Hauptthemen laut MEDLINE: Anti-Asthmatic Agents, Asthma, Pregnancy Complications, Abnormalities, Drug-Induced. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Canada Foundation for Innovation, Canadian Institutes of Health Research, FRQS.
Abstract (Originalsprache)
BACKGROUND Evidence regarding the safety of asthma controller medications (particularly montelukast) for the fetus remains insufficient and controversial. OBJECTIVE We sought to comprehensively evaluate the association between first-trimester use of 5 common asthma controller regimens and the risk of major congenital malformations in the offspring of women with asthma. METHODS We conducted a population-based cohort study using data from the AMerican PREGNANcy Mother-Child CohorT (AM-PREGNANT) from 2003 to 2021, which primarily comprises individuals with private insurance coverage in the United States. Singleton live births to mothers with asthma were included. Exposure was based on first-trimester prescription fills for asthma controller medications. The outcomes included major congenital malformations overall, organ-specific malformations, and 2 specific defects. RESULTS We identified 44,435 eligible pregnancies. Compared with the no asthma controller medication group, none of the 5 controller medication groups (montelukast monotherapy, inhaled corticosteroid [ICS] monotherapy, ICS + long-acting β2-adrenergic agonist [LABA] combination, montelukast + ICS combination, montelukast + ICS + LABA combination) was associated with an increased risk of major congenital malformations. The montelukast + ICS combination group was associated with an increased risk of cleft palate and/or lip compared with the no asthma controller medication group, but the number of events was limited (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center, CHU Sainte-Justine, Montreal, Quebec, Canada; Department of Pharmacy/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China; Children's Medicine Key La…
- Research Center, CHU Sainte-Justine, Montreal, Quebec, Canada.
- Clinical Research and Knowledge Transfer Unit on Childhood Asthma, CHU Sainte-Justine, Montreal, Quebec, Canada; Department of Pediatrics, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada; Departmen…
- Department of Pediatrics, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada; Department of Pediatrics, Division of Respiratory Medicine, CHU Sainte-Justine, Montreal, Quebec, Canada.
- Research Center, CHU Sainte-Justine, Montreal, Quebec, Canada; Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada; Faculty of Medicine, Université Claude Bernard Lyon 1, Lyon, France. Electronic addre…
Förderung
- Canada Foundation for Innovation
- Canadian Institutes of Health Research
- FRQS
Zitieren
APA
Jiao, X. F., Leal, L. F., Ducharme, F. M., Tse, S. M., & Bérard, A. (2026). First-trimester asthma controller medication use and major congenital malformation risk in offspring of women with asthma: A nationwide population-based cohort study. Journal of Allergy and Clinical Immunology, 158(1), 52-61. https://doi.org/10.1016/j.jaci.2026.03.013
Vancouver
Jiao XF, Leal LF, Ducharme FM, Tse SM, Bérard A. First-trimester asthma controller medication use and major congenital malformation risk in offspring of women with asthma: A nationwide population-based cohort study. Journal of Allergy and Clinical Immunology. 2026;158(1):52-61. doi:10.1016/j.jaci.2026.03.013
BibTeX
@article{Jiao2026,
author = {Jiao, Xue-Feng and Leal, Lisiane Freitas and Ducharme, Francine M and Tse, Sze Man and Bérard, Anick},
title = {First-trimester asthma controller medication use and major congenital malformation risk in offspring of women with asthma: A nationwide population-based cohort study},
journal = {Journal of Allergy and Clinical Immunology},
year = {2026},
volume = {158},
number = {1},
pages = {52--61},
doi = {10.1016/j.jaci.2026.03.013}
}
EUVIMED